Literature DB >> 29126138

"Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications.

Laura C Kennedy1, Ingrid A Binswanger1,2, Shane R Mueller1,2,3, Cari Levy4,5, Daniel D Matlock6,7, Susan L Calcaterra1,8, Stephen Koester3,9, Joseph W Frank1,5.   

Abstract

Objective: Given the risks of long-term opioid therapy, patients may benefit from tapering these medications. There is little evidence to guide providers' approach to this process. We explored primary care providers' experiences discussing and implementing opioid tapering with patients on long-term opioid therapy. Design: Qualitative study using six semistructured, in-person focus groups. Subject: Primary care providers (N = 40). Setting: Six academically affiliated primary care clinics in university, urban safety net, and Veterans Health Administration medical centers in Colorado.
Methods: Focus groups were audio-recorded, transcribed, and analyzed using a mixed inductive-deductive approach in ATLAS.ti. Emergent themes were identified through an iterative, multidisciplinary team-based process.
Results: We identified 1) strategies for identifying candidates for opioid tapering, 2) barriers to opioid tapering, and 3) facilitators of opioid tapering. Strategies for identifying candidates for opioid tapering included evidence of high-risk behavior, serious adverse events, opioid-related side effects, and patient preference. Barriers included the providers' emotional burden, inadequate resources, and a lack of trust between patient and provider. Facilitators of opioid tapering included empathizing with the patient's experience, preparing patients for opioid tapering, individualizing implementation of opioid tapering, and supportive guidelines and policies. Conclusions: While discussing and implementing opioid tapering present significant challenges, primary care providers described key facilitators. These findings suggest a need to develop and test the effectiveness of resources to support patient-centered opioid tapering and locally developed policies to support and standardize providers' approaches to opioid prescribing.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29126138      PMCID: PMC6454789          DOI: 10.1093/pm/pnx276

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  30 in total

1.  The economic costs of pain in the United States.

Authors:  Darrell J Gaskin; Patrick Richard
Journal:  J Pain       Date:  2012-05-16       Impact factor: 5.820

2.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-11-04       Impact factor: 17.586

Review 3.  Police officer, deal-maker, or health care provider? Moving to a patient-centered framework for chronic opioid management.

Authors:  Christina Nicolaidis
Journal:  Pain Med       Date:  2011-05-03       Impact factor: 3.750

4.  Association between opioid prescribing patterns and opioid overdose-related deaths.

Authors:  Amy S B Bohnert; Marcia Valenstein; Matthew J Bair; Dara Ganoczy; John F McCarthy; Mark A Ilgen; Frederic C Blow
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

5.  Opioid dose and risk of road trauma in Canada: a population-based study.

Authors:  Tara Gomes; Donald A Redelmeier; David N Juurlink; Irfan A Dhalla; Ximena Camacho; Muhammad M Mamdani
Journal:  JAMA Intern Med       Date:  2013-02-11       Impact factor: 21.873

6.  Trends in long-term opioid therapy for chronic non-cancer pain.

Authors:  Denise Boudreau; Michael Von Korff; Carolyn M Rutter; Kathleen Saunders; G Thomas Ray; Mark D Sullivan; Cynthia I Campbell; Joseph O Merrill; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-12       Impact factor: 2.890

7.  Contrasting tensions between patients and PCPs in chronic pain management: a qualitative study.

Authors:  Alicia A Bergman; Marianne S Matthias; Jessica M Coffing; Erin E Krebs
Journal:  Pain Med       Date:  2013-07-19       Impact factor: 3.750

8.  "I'm not abusing or anything": patient-physician communication about opioid treatment in chronic pain.

Authors:  Marianne S Matthias; Erin E Krebs; Linda A Collins; Alicia A Bergman; Jessica Coffing; Matthew J Bair
Journal:  Patient Educ Couns       Date:  2013-08-02

9.  "They don't want anything to do with you": patient views of primary care management of chronic pain.

Authors:  Carole C Upshur; Gonzalo Bacigalupe; Roger Luckmann
Journal:  Pain Med       Date:  2010-10-01       Impact factor: 3.750

Review 10.  Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals' perceptions.

Authors:  France Légaré; Stéphane Ratté; Karine Gravel; Ian D Graham
Journal:  Patient Educ Couns       Date:  2008-08-26
View more
  27 in total

1.  Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study.

Authors:  Hector R Perez; Michele Buonora; Chinazo O Cunningham; Moonseong Heo; Joanna L Starrels
Journal:  J Gen Intern Med       Date:  2019-08-19       Impact factor: 5.128

2.  Center Predictors of Long-Term Benzodiazepine Use in Chronic Obstructive Pulmonary Disease and Post-traumatic Stress Disorder.

Authors:  Lucas M Donovan; Carol A Malte; Laura J Spece; Matthew F Griffith; Laura C Feemster; Steven B Zeliadt; David H Au; Eric J Hawkins
Journal:  Ann Am Thorac Soc       Date:  2019-09

3.  Patients' Experience With Opioid Tapering: A Conceptual Model With Recommendations for Clinicians.

Authors:  Stephen G Henry; Debora A Paterniti; Bo Feng; Ana-Maria Iosif; Richard L Kravitz; Gary Weinberg; Penney Cowan; Susan Verba
Journal:  J Pain       Date:  2018-09-20       Impact factor: 5.820

4.  "It Sometimes Doesn't Even Work": Patient Opioid Assessments as Clues to Therapeutic Flexibility in Primary Care.

Authors:  Stephen G Henry; Melissa M Gosdin; Anne E C White; Richard L Kravitz
Journal:  J Gen Intern Med       Date:  2019-10-28       Impact factor: 5.128

5.  Correlates of Benzodiazepine Use and Adverse Outcomes Among Patients with Chronic Pain Prescribed Long-term Opioid Therapy.

Authors:  Bobbi Jo H Yarborough; Scott P Stumbo; Ashley Stoneburner; Ning Smith; Steven K Dobscha; Richard A Deyo; Benjamin J Morasco
Journal:  Pain Med       Date:  2019-06-01       Impact factor: 3.750

6.  "I felt like I had a scarlet letter": Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain.

Authors:  Allyn Benintendi; Sarah Kosakowski; Pooja Lagisetty; Marc Larochelle; Amy S B Bohnert; Angela R Bazzi
Journal:  Drug Alcohol Depend       Date:  2021-03-18       Impact factor: 4.492

7.  Design considerations for a remote randomized multi-site clinical trial evaluating an e-health self-management program for chronic pain patients receiving opioid therapy.

Authors:  Theresa Winhusen; Marian Wilson; Rowena J Dolor; Jeff Theobald; Daniel Lewis; Saundra L Regan; Mary Beth Vonder Meulen
Journal:  Contemp Clin Trials       Date:  2020-12-10       Impact factor: 2.226

8.  Factors associated with opioid-tapering success: A mixed methods study.

Authors:  Jennifer L Kuntz; John F Dickerson; Jennifer L Schneider; Alison J Firemark; Dea Papajorgji-Taylor; Matthew Slaughter; Katherine R Reese; Lou Ann Thorsness; Mark D Sullivan; Lynn L Debar; David H Smith
Journal:  J Am Pharm Assoc (2003)       Date:  2021-01-21

9.  "We Need to Taper." Interviews with Clinicians and Pharmacists About Use of a Pharmacy-Led Opioid Tapering Program.

Authors:  Alison J Firemark; Jennifer L Schneider; Jennifer L Kuntz; Dea Papajorgji-Taylor; John F Dickerson; Lou Ann Thorsness; Katherine R Reese; Mark D Sullivan; Lynn L Debar; David H Smith
Journal:  Pain Med       Date:  2021-05-21       Impact factor: 3.750

10.  Association Between Opioid Dose Reduction Against Patients' Wishes and Change in Pain Severity.

Authors:  Joseph W Frank; Evan Carey; Charlotte Nolan; Anne Hale; Sean Nugent; Erin E Krebs
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.